Key result
Review evaluates antiplatelet efficacy and safety for VTE prophylaxis following hip and knee arthroplasty.
Why the study?
There is no consensus on the best way to prevent thrombosis after THA and TKA, and literature on the dosage, duration, efficacy, and safety of antithrombotic drugs varies considerably.
Do antiplatelet agents improve efficacy and safety for VTE prophylaxis in patients in the postoperative period of total hip and knee arthroplasty?
Population
Patients in the postoperative period of THA or TKA
Comparison
Antiplatelet agents for VTE prophylaxis
Design
Literature review
Authors
Loading...
Evidence on antiplatelet VTE prophylaxis after hip/knee arthroplasty remains inconclusive; leaves open need for dedicated RCTs.
Do antiplatelet agents improve efficacy and safety for VTE prophylaxis in patients in the postoperative period of total hip and knee arthroplasty?
This review assesses the efficacy and safety of antiplatelet agents for VTE prophylaxis following total hip and knee arthroplasty.
Ushanova et al. (2023) conducted a review in Postoperative total hip and knee arthroplasty. Antiplatelet agents was evaluated on Efficacy and safety of antiplatelet agents for VTE prophylaxis. This review assessed published literature on the efficacy and safety of antiplatelet agents for venous thromboembolism prophylaxis following total hip and knee arthroplasty.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: